大葉大學圖書館 |

Medullary thyroid carcinoma[electronic resource] :biology, management, treatment /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	616.99444
書名/作者:	Medullary thyroid carcinoma : biology, management, treatment // edited by Friedhelm Raue.
其他作者:	Raue, Friedhelm.
出版者:	Cham : : Springer International Publishing :, 2015.
面頁冊數:	viii, 249 p. : : ill., digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Thyroid gland - Cancer.
標題:	Medicine & Public Health.
標題:	Oncology.
標題:	Endocrinology.
標題:	Human Genetics.
標題:	Nuclear Medicine.
ISBN:	9783319225425
ISBN:	9783319225418
內容註:	Thyroid C-Cell Biology and Oncogenic Transformation -- Histopathology of C cells and medullary thyroid carcinoma -- Epidemiology and clinical presentation of Medullary Thyroid Carcinoma -- Medullary thyroid carcinoma: Imaging -- Calcitonin as a Biomarker for Medullary Thyroid Carcinoma -- Hereditary Medullary Thyroid Cancer, Genotype phenotype correlation -- Pheochromocytomas in Multiple Endocrine Neoplasia 2 -- Primary hyperparathyroidism in Multiple Endocrine Neoplasia 2 Syndrome -- Surgical treatment of medullary thyroid carcinoma -- Long term follow up in medullary thyroid carcinoma -- Use of Tyrosine Kinase Inhibitors for Treatment of Medullary Thyroid Carcinoma.
摘要、提要註:	This book offers a comprehensive overview of medullary thyroid carcinoma, both in the more common sporadic form and in the familial form, multiple endocrine neoplasia (MEN) types 2A and 2B. The coverage includes, but is not limited to, molecular biology and genetics, pathology, clinical presentation, imaging techniques, surgical treatment, and follow-up. The role of calcitonin as a highly sensitive and specific tumor marker for the screening, diagnosis, and follow-up of MTC and metastatic disease is described, and the significance of other tumor markers is also considered. With regard to treatment, the use of thyroidectomy is fully discussed, including in children carrying the mutations in the RET proto-oncogene considered causative for MEN 2. Additionally, the value of tyrosine kinase inhibitors as the most effective treatment modality in patients with a large tumor burden or rapid tumor growth, or both, is explained. Medullary Thyroid Carcinoma and Multiple Endocrine Neoplasia Type 2 will be an ideal source of up-to-date information for a wide range of practitioners, including endocrinologists, oncologists, internal medicine specialists, geneticists, and nuclear medicine physicians.
電子資源:	http://dx.doi.org/10.1007/978-3-319-22542-5

Medullary thyroid carcinoma[electronic resource] :biology, management, treatment /
Medullary thyroid carcinomabiology, management, treatment /[electronic resource] :edited by Friedhelm Raue. - Cham :Springer International Publishing :2015. - viii, 249 p. :ill., digital ;24 cm. - Recent results in cancer research,v.2040080-0015 ;. - Recent results in cancer research ;v.192..

Thyroid C-Cell Biology and Oncogenic Transformation -- Histopathology of C cells and medullary thyroid carcinoma -- Epidemiology and clinical presentation of Medullary Thyroid Carcinoma -- Medullary thyroid carcinoma: Imaging -- Calcitonin as a Biomarker for Medullary Thyroid Carcinoma -- Hereditary Medullary Thyroid Cancer, Genotype phenotype correlation -- Pheochromocytomas in Multiple Endocrine Neoplasia 2 -- Primary hyperparathyroidism in Multiple Endocrine Neoplasia 2 Syndrome -- Surgical treatment of medullary thyroid carcinoma -- Long term follow up in medullary thyroid carcinoma -- Use of Tyrosine Kinase Inhibitors for Treatment of Medullary Thyroid Carcinoma.

This book offers a comprehensive overview of medullary thyroid carcinoma, both in the more common sporadic form and in the familial form, multiple endocrine neoplasia (MEN) types 2A and 2B. The coverage includes, but is not limited to, molecular biology and genetics, pathology, clinical presentation, imaging techniques, surgical treatment, and follow-up. The role of calcitonin as a highly sensitive and specific tumor marker for the screening, diagnosis, and follow-up of MTC and metastatic disease is described, and the significance of other tumor markers is also considered. With regard to treatment, the use of thyroidectomy is fully discussed, including in children carrying the mutations in the RET proto-oncogene considered causative for MEN 2. Additionally, the value of tyrosine kinase inhibitors as the most effective treatment modality in patients with a large tumor burden or rapid tumor growth, or both, is explained. Medullary Thyroid Carcinoma and Multiple Endocrine Neoplasia Type 2 will be an ideal source of up-to-date information for a wide range of practitioners, including endocrinologists, oncologists, internal medicine specialists, geneticists, and nuclear medicine physicians.

ISBN: 9783319225425

Standard No.: 10.1007/978-3-319-22542-5doiSubjects--Topical Terms:

428254
Thyroid gland
--Cancer.

LC Class. No.: RC261

Dewey Class. No.: 616.99444

Medullary thyroid carcinoma[electronic resource] :biology, management, treatment /
LDR:02884nam a2200325 a 4500 001 444400
003 DE-He213
005 20160411132108.0
006 m d
007 cr nn 008maaau
008 160715s2015 gw s 0 eng d
020 $a 9783319225425 $q (electronic bk.)
020 $a 9783319225418 $q (paper)
024 7 $a 10.1007/978-3-319-22542-5 $2 doi
035 $a 978-3-319-22542-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RC261
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.99444 $2 23
090 $a RC261 $b .M493 2015
245 0 0 $a Medullary thyroid carcinoma $h [electronic resource] : $b biology, management, treatment / $c edited by Friedhelm Raue.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a viii, 249 p. : $b ill., digital ; $c 24 cm.
490 1 $a Recent results in cancer research, $x 0080-0015 ; $v v.204
505 0 $a Thyroid C-Cell Biology and Oncogenic Transformation -- Histopathology of C cells and medullary thyroid carcinoma -- Epidemiology and clinical presentation of Medullary Thyroid Carcinoma -- Medullary thyroid carcinoma: Imaging -- Calcitonin as a Biomarker for Medullary Thyroid Carcinoma -- Hereditary Medullary Thyroid Cancer, Genotype phenotype correlation -- Pheochromocytomas in Multiple Endocrine Neoplasia 2 -- Primary hyperparathyroidism in Multiple Endocrine Neoplasia 2 Syndrome -- Surgical treatment of medullary thyroid carcinoma -- Long term follow up in medullary thyroid carcinoma -- Use of Tyrosine Kinase Inhibitors for Treatment of Medullary Thyroid Carcinoma.
520 $a This book offers a comprehensive overview of medullary thyroid carcinoma, both in the more common sporadic form and in the familial form, multiple endocrine neoplasia (MEN) types 2A and 2B. The coverage includes, but is not limited to, molecular biology and genetics, pathology, clinical presentation, imaging techniques, surgical treatment, and follow-up. The role of calcitonin as a highly sensitive and specific tumor marker for the screening, diagnosis, and follow-up of MTC and metastatic disease is described, and the significance of other tumor markers is also considered. With regard to treatment, the use of thyroidectomy is fully discussed, including in children carrying the mutations in the RET proto-oncogene considered causative for MEN 2. Additionally, the value of tyrosine kinase inhibitors as the most effective treatment modality in patients with a large tumor burden or rapid tumor growth, or both, is explained. Medullary Thyroid Carcinoma and Multiple Endocrine Neoplasia Type 2 will be an ideal source of up-to-date information for a wide range of practitioners, including endocrinologists, oncologists, internal medicine specialists, geneticists, and nuclear medicine physicians.
650 0 $a Thyroid gland $x Cancer. $3 428254
650 1 4 $a Medicine & Public Health. $3 463493
650 2 4 $a Oncology. $3 205017
650 2 4 $a Endocrinology. $3 406699
650 2 4 $a Human Genetics. $3 464334
650 2 4 $a Nuclear Medicine. $3 464181
700 1 $a Raue, Friedhelm. $3 635931
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
830 0 $a Recent results in cancer research ; $v v.192. $3 468540
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-22542-5
950 $a Medicine (Springer-11650)